Climb Bio Inc (CLYM) Balance Sheet
As of 2026-06-30 (10-Q), Climb Bio Inc (CLYM) reported total assets of $246.3M, total liabilities of $6.7M and shareholders' equity of $239.5M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $44.1M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CLYMClimb Bio IncFollow CLYM — free
—
Price chart with a free account
- Market cap
- 585.3M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 17 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 46.9 | 43.6 | 93.1 | 87.2 | 35.7 | 44.1 | |
| Short-term investments | 89.6 | 80.0 | 13.7 | 63.7 | 65.4 | 139.0 | |
| Current assets | 148.3 | 134.4 | 110.3 | 154.9 | 105.8 | 186.6 | |
| Total assets | 173.2 | 135.0 | 110.5 | 217.2 | 167.7 | 246.3 | |
| Current liabilities | 6.0 | 6.1 | 2.8 | 4.9 | 7.0 | 5.9 | |
| Total liabilities | 6.0 | 6.3 | 2.9 | 5.3 | 7.3 | 6.7 | |
| Shareholders' equity | 167.2 | 128.7 | 107.6 | 211.9 | 160.5 | 239.5 |
USD millions · SEC XBRL
Climb Bio Inc — questions
- How much cash does Climb Bio Inc have?
- $44.1M in cash and cash equivalents as of 2026-06-30.
- What are Climb Bio Inc's total assets?
- $246.3M as of 2026-06-30.
- What is Climb Bio Inc's shareholders' equity?
- $239.5M as of 2026-06-30.
Every figure on this page comes from Climb Bio Inc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.